Hepatitis C Virus Reinfection and Injecting Risk Behavior Following Elbasvir/Grazoprevir Treatment In Participants on Opiate Agonist Therapy: C-EDGE CO-STAR Part B. AASLD Annual Meeting, October 22nd 2017. Washington, D.C.

Top